Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 450.00 | 691.00 | 0.6512 | 0.2808 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 722.00 | 691.00 | 1.0449 | 1.0933 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 750.00 | 691.00 | 1.0854 | 1.1777 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 625.00 | 354.63 | 480.00 | 691.00 | 0.6947 | 0.3697 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 625.00 | 354.63 | 378.00 | 691.00 | 0.5470 | 0.0686 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 625.00 | 354.63 | 626.00 | 691.00 | 0.9059 | 0.8049 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 612.00 | 691.00 | 0.8857 | 0.7630 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 691.00 | 0.0029 | -0.9954 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 4.00 | 2002.25 | 0.0020 | -0.9878 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1493.00 | 2002.25 | 0.7457 | 0.5723 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2067.00 | 2002.25 | 1.0323 | 1.0529 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 1250.00 | 859.67 | 701.00 | 2002.25 | 0.3501 | -0.1540 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1680.00 | 2002.25 | 0.8391 | 0.7320 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1098.00 | 2002.25 | 0.5484 | 0.2222 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1523.00 | 2002.25 | 0.7606 | 0.5982 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 1250.00 | 859.67 | 1723.00 | 2002.25 | 0.8605 | 0.7683 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 1250.00 | 859.67 | 2039.00 | 2002.25 | 1.0184 | 1.0300 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2243.00 | 2002.25 | 1.1202 | 1.1951 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 2367.00 | 2002.25 | 1.1822 | 1.2941 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 2170.00 | 2002.25 | 1.0838 | 1.1364 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1369.00 | 2002.25 | 0.6837 | 0.4644 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 2029.00 | 2002.25 | 1.0134 | 1.0219 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 1250.00 | 859.67 | 960.00 | 2002.25 | 0.4795 | 0.0947 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 1257.00 | 2002.25 | 0.6278 | 0.3655 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 1250.00 | 859.67 | 929.00 | 2002.25 | 0.4640 | 0.0657 |